A detailed history of Smithbridge Asset Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Smithbridge Asset Management Inc holds 2,805 shares of MRK stock, worth $330,569. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,805
Previous 2,639 6.29%
Holding current value
$330,569
Previous $348,000 0.29%
% of portfolio
0.07%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$123.8 - $132.96 $20,550 - $22,071
166 Added 6.29%
2,805 $347,000
Q4 2023

Jan 18, 2024

SELL
$100.18 - $109.02 $11,520 - $12,537
-115 Reduced 4.18%
2,639 $288,000
Q3 2023

Oct 25, 2023

BUY
$102.95 - $114.33 $25,737 - $28,582
250 Added 9.98%
2,754 $284,000
Q2 2023

Jul 20, 2023

BUY
$108.61 - $118.38 $271,959 - $296,423
2,504 New
2,504 $289,000
Q1 2023

Apr 20, 2023

BUY
$102.94 - $114.86 $245,923 - $274,400
2,389 New
2,389 $254,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $299B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Smithbridge Asset Management Inc Portfolio

Follow Smithbridge Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithbridge Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Smithbridge Asset Management Inc with notifications on news.